Stockholders’ Equity (Details Narrative) - USD ($)
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
|
Dec. 29, 2023 |
Dec. 28, 2023 |
Sep. 22, 2023 |
Sep. 22, 2023 |
Oct. 31, 2023 |
Sep. 30, 2023 |
Feb. 29, 2024 |
May 31, 2024 |
May 31, 2023 |
Dec. 29, 2024 |
Feb. 29, 2024 |
Feb. 28, 2023 |
Mar. 08, 2024 |
Feb. 22, 2024 |
Jan. 26, 2024 |
Jan. 04, 2024 |
Oct. 12, 2023 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
1,200,000
|
250,000,000
|
|
|
1,200,000
|
1,200,000
|
|
|
|
|
|
| Common stock, shares issued |
|
|
|
|
|
|
936,430
|
1,345,932
|
|
|
936,430
|
83,371
|
|
|
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
936,430
|
1,345,932
|
|
|
936,430
|
83,371
|
|
|
|
|
780,423
|
| Common stock, par value |
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
|
|
| Reverse stock split |
|
|
1-for-20 reverse stock split
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse stock split issued common shares |
|
|
|
40,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
|
|
|
|
|
|
$ 1,905,970
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
10,000,000
|
10,000,000
|
|
|
10,000,000
|
10,000,000
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
472,996
|
63,494
|
|
|
472,996
|
0
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
472,996
|
63,494
|
|
|
472,996
|
0
|
|
|
|
|
|
| Reverse acquisition shares outstanding |
|
|
|
|
|
|
85,300
|
79,560
|
|
|
85,300
|
|
|
|
|
|
|
| Weighted average exercise price |
|
|
|
|
|
|
$ 60.50
|
$ 59.84
|
|
|
$ 60.50
|
|
|
|
|
|
|
| Common stock reserved for future issuance |
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
| Share based compensation arrangement by award options vested |
|
|
|
|
|
|
|
|
|
|
6,914
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
$ 116,512
|
|
|
|
|
|
|
| Stock issued during Stock options exercised |
|
|
|
|
|
|
81,849
|
76,988
|
|
|
81,849
|
|
|
|
|
|
|
| Shares issued or exercised |
|
|
|
|
|
|
|
(0)
|
|
|
0
|
|
|
|
|
|
|
| Number of options issued |
|
|
|
|
|
|
|
|
|
|
86,642
|
|
|
|
|
|
|
| Shares forfeited or expired |
|
|
|
|
|
|
1,342
|
5,740
|
|
|
1,342
|
|
|
|
|
|
|
| Allocation share based compensation expense |
|
|
|
|
|
|
|
$ 16,394
|
|
|
$ 116,512
|
|
|
|
|
|
|
| Options exercise price |
|
|
|
|
|
|
|
$ 2.37
|
|
|
$ 2.99
|
|
|
|
|
|
|
| Unrecognized stock-based compensation expense |
|
|
|
|
|
|
$ 52,615
|
|
|
|
$ 52,615
|
|
|
|
|
|
|
| Weighted average remaining recognition period |
|
|
|
|
|
|
|
|
|
|
11 months 19 days
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
250,000,000
|
|
|
|
|
| Number of options issued |
|
|
|
|
|
|
|
|
|
|
86,402
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
1,200,000
|
|
|
|
|
| Equity Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse acquisition shares outstanding |
|
|
|
|
|
|
85,300
|
|
|
|
85,300
|
|
|
|
|
|
|
| Stock Appreciation Rights [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse acquisition shares outstanding |
40,390
|
|
|
|
|
|
40,390
|
40,223
|
|
|
40,390
|
|
|
|
|
|
|
| Weighted average exercise price |
|
|
|
|
|
|
$ 44.77
|
$ 44.80
|
|
|
$ 44.77
|
|
|
|
|
|
|
| Stock issued during Stock options exercised |
|
|
|
|
|
|
33,504
|
33,553
|
|
|
33,504
|
|
|
|
|
|
|
| Shares issued or exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of options issued |
|
|
|
|
|
|
|
|
|
|
40,390
|
|
|
|
|
|
|
| Shares forfeited or expired |
|
|
|
|
|
|
|
167
|
|
|
|
|
|
|
|
|
|
| Options exercise price |
|
|
|
|
|
|
|
$ 2.37
|
|
|
|
|
|
|
|
|
|
| Unrecognized stock-based compensation expense |
|
|
|
|
|
|
|
$ 1,122
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining recognition period |
|
|
|
|
|
|
|
10 months 6 days
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
1,047,300
|
|
|
|
1,047,300
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
$ 16,394
|
$ 0
|
|
|
|
|
|
|
|
|
| Stock issued during Stock options exercised |
|
|
|
|
|
|
85,300
|
79,560
|
|
|
85,300
|
|
|
|
|
|
|
| Number of options issued |
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
|
|
|
| Unrecognized stock-based compensation expense |
|
|
|
|
|
|
|
$ 29,980
|
|
|
|
|
|
|
|
|
|
| Weighted average remaining recognition period |
|
|
|
|
|
|
|
9 months 7 days
|
|
|
|
|
|
|
|
|
|
| 2013 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse acquisition shares outstanding |
|
|
|
|
|
|
85,300
|
|
|
|
85,300
|
|
|
|
|
|
|
| Weighted average exercise price |
|
|
|
|
|
|
$ 60.50
|
|
|
|
$ 60.50
|
|
|
|
|
|
|
| 2023 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock reserved for future issuance |
|
7,000,000
|
|
|
|
|
7,000,000
|
7,000,000
|
|
|
7,000,000
|
|
|
|
|
|
|
| Common stock shares equity award issued or granted |
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2013 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse acquisition shares outstanding |
|
|
|
|
|
|
82,800
|
|
|
|
82,800
|
|
|
|
|
|
|
| 2020 Stock Appreciation Rights Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
$ 10,107
|
|
|
|
|
|
|
| Options exercise price |
|
|
|
|
|
|
|
|
|
|
$ 2.99
|
|
|
|
|
|
|
| Unrecognized share based compensation cost |
|
|
|
|
|
|
$ 79,978
|
|
|
|
$ 79,978
|
|
|
|
|
|
|
| Weighted average remaining recognition period |
|
|
|
|
|
|
|
|
|
|
1 year 29 days
|
|
|
|
|
|
|
| Series E Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
$ 1,500
|
$ 1,500
|
|
|
$ 1,500
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
316
|
316
|
|
|
316
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
316
|
316
|
|
|
316
|
|
|
|
|
|
|
| Dividends percentage |
|
|
|
|
|
|
|
9.00%
|
|
|
9.00%
|
|
|
|
|
|
|
| Conversion price per share |
|
|
|
|
|
|
$ 0.13
|
$ 0.13
|
|
|
$ 0.13
|
|
|
|
|
|
|
| Issuance of common stock dividends, shares |
|
|
|
|
|
|
|
|
|
|
3,155
|
|
|
|
|
|
|
| Common stock issuable upon conversion |
|
|
|
|
|
|
|
3,207
|
|
|
|
|
|
|
|
|
|
| Series F Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,843,993
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
0
|
0
|
|
|
0
|
|
|
|
|
|
|
| Series G Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
100,000
|
0
|
|
|
100,000
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
100,000
|
0
|
|
|
100,000
|
|
|
|
|
|
|
| Preferred stock redemption right, description |
|
|
|
|
|
|
|
The
Company shall have the right to redeem up to 50% of the Series G Preferred Stock for an aggregate price of $1.00 in accordance with
the terms of the Perpetual License Agreement
|
|
|
The Company shall have the right to redeem up to 50% of the Preferred Stock for an aggregate price of $1.00 in accordance
with the terms of the Perpetual License Agreement
|
|
|
|
|
|
|
| Common stock issuable upon conversion |
|
|
|
|
|
|
100,000
|
|
|
|
100,000
|
|
|
|
|
|
|
| Number of common stock issued |
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
| Number of shares converted |
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
| Series H Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
150,000
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
150,000
|
33,000
|
|
|
150,000
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
150,000
|
33,000
|
|
|
150,000
|
|
|
|
|
|
|
| Common stock issuable upon conversion |
|
|
|
|
|
|
150,000
|
33,000
|
|
|
150,000
|
|
|
|
|
|
|
| Number of common stock issued |
|
|
|
|
|
|
|
117,000
|
|
|
|
|
|
|
|
|
|
| Number of shares converted |
|
|
|
|
|
|
|
117,000
|
|
|
|
|
|
|
|
|
|
| Series I Convertible Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
331,124
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
222,680
|
30,178
|
|
|
222,680
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
222,680
|
30,178
|
|
|
222,680
|
|
|
|
|
|
|
| Common stock issuable upon conversion |
|
|
|
|
|
|
222,680
|
30,178
|
|
|
222,680
|
|
|
|
|
|
|
| Number of common stock issued |
|
|
|
|
|
|
|
192,502
|
|
|
|
|
|
|
|
|
|
| Number of shares converted |
|
|
|
|
|
|
|
192,502
|
|
|
|
|
|
|
|
|
|
| Next Trip Holdings Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity interest acquired |
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted shares issued in acquisitions |
156,007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of issued and outstanding common shares |
|
|
|
|
|
|
|
|
|
19.99%
|
|
|
|
|
|
|
|
| Shares issuable for consideration |
5,843,993
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in acquisitions |
83,371
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Next Trip Holdings Inc [Member] | Third Party Consultant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued during period services |
4,337
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Next Trip Holdings Inc [Member] | Debt Assignment and Conversion Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued in acquisitions |
52,818
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Next Trip Holdings Inc [Member] | Share Purchase And Exchange Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of shares issued |
15,481
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued during period services |
|
|
|
|
|
|
|
|
|
|
4,337
|
|
|
|
|
|
|
| Number of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
13,001
|
|
|
|
|
|
| Number of shares converted |
52,818
|
|
|
|
|
|
|
409,502
|
|
|
52,818
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase of outstanding warrants |
|
|
|
|
|
|
486,165
|
|
|
|
486,165
|
|
|
|
|
|
|
| Warrant description |
|
|
|
|
|
|
|
|
|
|
expire between March 15, 2024 and January 25, 2028
|
|
|
|
|
|
|
| Warrant [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise price |
|
|
|
|
|
|
$ 350.00
|
|
|
|
$ 350.00
|
|
|
|
|
|
|
| Warrant [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercise price |
|
|
|
|
|
|
$ 3.02
|
|
|
|
$ 3.02
|
|
|
|
|
|
|
| At-The-Market Issuance Sales Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued and sold during period, shares |
|
|
|
|
128,887
|
72,721
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds |
|
|
|
|
$ 772,468
|
$ 364,555
|
|
|
|
|
|
|
|
|
|
|
|